“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease

According to a new study, a combination of a cancer vaccine from Norwegian company Ultimovacs and two immunotherapies significantly prolonged survival in cases ...

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Deras samarbete ska ge ett pulvervaccin mot influensa

De bägge Uppsalabolagen Abera Bioscience och Orexo inleder ett samarbete för att ta fram vaccin i pulverform mot bland annat influensa.

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Digital Temperature Sensors from ZEISS

New Metrology Expert Tip video.

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Specific proposals and targets top the universities’ desired priorities

What are the universities’ expectations for the update of the national life science strategy? Life Science Sweden posed the question to representatives from Kar...

A new giant among our microscopes

Two technologies in one machine.

Ånga: Spara energi och minska CO2-utsläppen

Med ett ökat fokus på att minska CO2-utsläppen i energiintensiva produktionsprocesser är företagare och operatörer måna om att minska energiförbrukningen och avfallet.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Key2brain i licensavtal med italiensk läkemedelsjätte

Solnabaserade Key2brain har ingått ett licensavtal med italienska Chiesi Group om utveckling av terapier som kan passera blod-hjärnbarriären.

Study: Semaglutide tablet produces weight loss

The pharmaceutical semaglutide is effective for weight loss even when given in tablet form, according to a phase 3 study.

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!

Antikroppar tog form med hjälp av artificiell intelligens

Språkmodeller, såsom Chat GPT, som bygger på artificiell intelligens kan användas till en rad olika saker. Nu har forskare, med en språkmodell tillverkad av ett...

Norwegian company wins bidding battle for Sensidose

The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

Pharma Outsourcing – Find the Right Partner (2026)

Bioinvents antikropp går vidare till nästa fas: ”Viktig milstolpe”

Det svenska bioteknikbolaget Bioinvent har inlett en klinisk fas IIa-studie för att utvärdera sin läkemedelskandidat BI-1206 i kombination med Keytruda (pembrol...